NCT04899466View on ClinicalTrials.gov

Efficacy Evaluation of ActiGraft in Secondary Closure of Abdominal Surgical Wound Dehiscence

NARecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2026

Conditions

Dehiscence Wound

Interventions

DEVICE

ActiGraft

Whole blood clot (WBC) gel

Trial Locations (1)

Unknown

RECRUITING

Meir Medical Center, Kfar Saba

All Listed Sponsors

lead

RedDress Ltd.

INDUSTRY